Study: 1 in 20 adults with RSV hospitalized within 28 days after infection

About 1 in 20 adults with respiratory syncytial virus (RSV) requires hospitalization within 28 days of infection. report Published on Tuesday JAMA Network Open shows.

Data were collected from RSV seasons 2016 through 2022. These data came from 67,239 people with RSV who contracted RSV during these six years. Three different databases were used. All people were diagnosed in outpatient settings.

In addition to a group of all adults, the researchers also evaluated a subgroup of people ages 65 and older who were known to be at high risk due to asthma, chronic obstructive pulmonary disease (COPD), or congestive heart failure.

The proportion of adults hospitalized with RSV was 6.2% in one database, 6% in a second database, and 4.5% in a third database. The amount of hospitalization in high-risk individuals was determined as 7.6%, 8.5% and 6.5% in the relevant databases.

The rate of hospitalizations for people aged 65 and over and those suffering from COPD, congestive heart failure or asthma was 90.6 percent in the first database, 74.5 percent in the second database and 80.4 percent in the last database.

The rate of hospitalizations among high-risk individuals aged 75 and over was 8.1%, 8.7% and 6.7%, respectively.

In related news, on November 13 to work An article published in the same journal found that RSV is linked to the heavy burden of intensive care unit (ICU) admissions, hospitalizations, and in-hospital deaths in adults. RSV vaccine Approved for use in the United States. Data was collected from seven seasons spanning from the 2016-2017 season to the 2022-2023 season.

The data showed that the highest burden was in the 2017-2018 season, when there were 8,620 in-hospital deaths. Older adults aged 75 years and older had the highest rates of hospitalization, intensive care unit admission, and in-hospital death due to RSV.